PULMONX CORPORATION: basic weighted-average shares

What this measure means

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Exact concept: us-gaap:WeightedAverageNumberOfSharesOutstandingBasic. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2020-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Reading these values

This selected numerical history matches Diluted weighted-average shares for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.

Context from the filing

Pulmonx's 2024 basic denominator subtracts 33 weighted-average shares subject to repurchase from 39,111,106 weighted-average shares, leaving 39,111,073. The corresponding 2025 repurchase adjustment is zero. Potentially dilutive securities are excluded during losses. Dollar losses are displayed in thousands; shares and per-share data are unscaled. Full selected denominators and reported USD EPS are preserved. Read the source filing.

Selected filing history

Related financial histories

• PULMONX CORPORATION: total assets
• PULMONX CORPORATION: total liabilities
• PULMONX CORPORATION: stockholders equity
• PULMONX CORPORATION: cash and cash equivalents
• PULMONX CORPORATION: net income or loss
• PULMONX CORPORATION: operating cash flow
• PULMONX CORPORATION: capital expenditure payments
• PULMONX CORPORATION: contract revenue excluding tax
• PULMONX CORPORATION: financing cash flow
• PULMONX CORPORATION: investing cash flow
• PULMONX CORPORATION: retained earnings or deficit
• PULMONX CORPORATION: diluted weighted-average shares
• PULMONX CORPORATION: basic earnings per share
• PULMONX CORPORATION: diluted earnings per share
• PULMONX CORPORATION: income tax expense or benefit
• PULMONX CORPORATION: net property, plant and equipment
• PULMONX CORPORATION: share-based compensation expense
• PULMONX CORPORATION: operating income or loss
• PULMONX CORPORATION: current assets
• PULMONX CORPORATION: interest expense
• PULMONX CORPORATION: current liabilities
• PULMONX CORPORATION: current accounts payable
• PULMONX CORPORATION: net finite-lived intangible assets
• PULMONX CORPORATION: net current accounts receivable
• PULMONX CORPORATION: common-stock repurchase payments
• PULMONX CORPORATION: operating expenses
• PULMONX CORPORATION: net inventory
• PULMONX CORPORATION: gross profit
• PULMONX CORPORATION: selling, general and administrative expense
• PULMONX CORPORATION: research and development expense

Inspect the source

Entity

PULMONX CORPORATION / CIK 0001127537

Captured

2026-09-20T07:40:39.344Z

SEC response SHA-256

96e51f9fc551fee743147286f90fb409fd8d90a37672ed916a566a541422b3ad

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001127537.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))